With COVID-19 putting an emphasis on frontline medical workers, more students are ready to put on a white coat themselves. Medical schools across the country report a spike in applications, especially from students of color.

At Georgetown Universitys medical school, applications are up 24% overall and 40% from underrepresented minorities. The University of Maryland along with Howard University have also seen a rising number of applicants.

Since the pandemic started, the passion I had has actually increased, said Eunice Odusanya, a senior at Howard University who recently applied to 16 medical schools.

Odusanya has dreamed of studying medicine since the first grade, when doctors helped her with asthma. She plans to go into surgical oncology. Odusanya lost her grandfather to cancer, and hopes to someday find a cure.

She also hopes to help communities of color, which have been hit hardest by COVID-19.

Who better to do it than us, when you see someone who looks like you, who has experienced the same thing that you have experienced? Odusanya said.

Dr. Hugh Mighty, dean of the Howard University College of Medicine, is uplifted to see a rise in applicants, especially from underrepresented groups. He said that many schools are doing virtual interviews, which makes it easier and more affordable for students to apply.

If you are a minority aspiring physician in this country, there is work to be done and you see that, Mighty said.

Odusanya was recently accepted into Howard Universitys medical school, but is still waiting to hear back from others before deciding. Wherever she ends up, shes certain that the pandemic has galvanized her passion.

It has actually motivated me to learn more, to grow more, and to be the best that I can be, Odusanya said. Because people are actually depending on my success.

Originally posted here:
More Students Applying to Medical School During the Pandemic, Universities Say - NBC4 Washington

With several cases of the highly infectious COVID-19 variant confirmed in Worcester, UMass Medical School researchers have doubled their efforts to track and trace the mutated infections in Central Massachusetts.

Their method? Genomic sequencing, which lets them determine the genetic makeup of virus samples that are collected through local testing efforts. The tracking project is being done in collaboration with the Broad Institute of Harvard and MIT and the Centers for Disease Control and Prevention.

The UMass researchers and their colleagues proposed the sequencing idea over the summer. They had done it before, originally as a way of trying to understand the role mutations played in the transmission of bacterial infections in hospitals.

We wanted to see how bacteria, such as MRSA, spreads in the hospital, said Dr. Richard Ellison, an epidemiologist at UMass Memorial Medical Center involved in the effort.

After several prominent strains of the COVID-19 emerged in different parts of the world, interest in the project grew. Last month, researchers began collecting COVID samples from routine PCR tests, sending them off to the Department of Public Health for sequencing. Those samples were previously flagged as suspicious by UMass researchers based on an analysis of the viruses genetic codes.

We use an instrument at UMass that looks for three different COVID genes, Ellison said. If you have the U.K. variant, a sample might test positive for two of the genes, but negative for another.

This pro-active targeting of available viral samples from Worcester residents led to the discovery of at least three cases of the B.1.1.7 COVID variant in Worcester, which first emerged in the United Kingdom in November. UMass researchers hope not only to continue identifying the mutated infections in the Worcester area, but work with local officials to determine if theyre clustered in a particular part of the city.

They can do this through contact tracing. Because viruses can pick up several mutations a week, epidemiologists can attempt to trace the samples that have identifiable changes back to the circumstances of transmission based on the likeness of their genome.

If one person gives the virus directly to another person, their sequences are essentially going to be identical, Ellison said.

As of Monday, there are at least 7 cases of B.1.1.7 in Massachusetts. The new strain is thought be caused by a mutation on the viruss spike protein, specifically the receptor-binding domain the part of the virus that docks onto the host cell. Experts believe that the vaccines are still effective, preventing the new variant from attaching to cells, injecting its genome and replicating.

But uncertainty lingers. Successful viral mutations may threaten the efficacy of the vaccines, and could potentially cause more severe illness, Ellison said.

Federal health officials on Monday reiterated that the U.K. mutation could become the dominant strain in the U.S. as early as March, a prediction based on CDC modeling. Genomic tracking efforts will ultimately be key to getting the pandemic under control, Ellison said.

But in the U.S., genomic sequencing capabilities have been lagging behind that of other countries, like the U.K.

The reason they could identify the variant in the U.K. was because they were routinely sequencing, Ellison said.

Its thanks to genomic sequencing that Broad Institute researchers and others discovered over the summer that more than 80 unique genomes of COVID-19 here in Massachusetts had been imported from other parts of the world. Researchers in that study also stated that the Biogen conference in Boston that took place at the onset of the pandemic was linked to tens of thousands of cases.

Related Content:

Follow this link:
UMass Medical School researchers are tracking COVID mutations in Worcester; Heres what theyre finding - MassLive.com

An audience cheered the first 60 Washington State University members of the Elson S. Floyd College of Medicine in August 2017. The future doctors in its inaugural class were cloaked in white coats during a ceremony at Martin Woldson Theater at the Fox.

This May likely absent a gathering WSU will graduate that first class of new MDs who then disperse to residency programs in this state and across the U.S. After an average of five years or so in that training, the hope is theyll return to this state to practice medicine.

Among them is Phoebe Tham, 29, who today can look from her downtown Spokane condo and see the theater where their collective journey began.

A little over 3 years ago now, we were all in the theater here for our white coat ceremony taking our oath before starting medical school, Tham said. The time has just flown by.

At that ceremony, the class also heard from Carmento Floyd, widow of the former WSU president for whom the medical school is named. She told them, You are and will be the most important class because you were first. That message has never been lost, Tham said.

Were all pretty close. I consider everyone a great classmate, a great friend and, really, a lifelong colleague. Its a very supportive group.

We all are part of this first class, and I think there is some pride in that and some pride in knowing we have a part in shaping what the future of the college of medicine looks like. I think weve all just embraced that opportunity whether thats working together, learning well and working well with the medical communities that were in.

Weve also had the privilege of kind of shaping what we want our legacy to be, to make improvements for future classes. To be able to work closely with the faculty and the community physicians has been a real privilege and something that I knew I would get as being part of the first class but didnt have the appreciation yet that I do now.

Tham has a goal to become an anesthesiologist, so shes applied to training programs that include two in the state, through the University of Washington as well as Virginia Mason Medical Center in Seattle. Another regional option is through Oregon Health & Science University in Portland.

On March 19, called match day among medical school graduates, she and others learn of their residency and fellowship training positions in the National Resident Matching Program. Shes keeping her fingers crossed that it will be a Northwest program, but, it could be anywhere.

Tham wants eventually to be in Washington either way.

When selected, all 60 of the medical students came from somewhere in the state, a move that college administrators said was purposeful to make a dent toward filling in future physician needs particularly for medically underserved areas.

That is one of the coolest things about being in this class is that I know in another four, five or six years, whenever were all done training, I would say most of the people I know have the goals of coming back to serve and be a physician in the state, Tham said.

Even though we are going into all different specialties whether that be surgery, family medicine or anesthesiology, just the thought that well all be back one day is really neat. I could be the anesthesiologist for one of my classmates who might be the surgeon.

There were a few bumps as the first class, she said, such as unknowns early on about what clinical rotations would look like, and they couldnt ask questions of an upper class of medical students.

But they instead received an abundance of support, she said, from Spokanes medical doctors going all out to mentor and train this first WSU group.

I think one of the things thats very much stood out to me is just how incredible the medical community in Spokane is. One of the things that Im most thankful for having the opportunity to do the clinicals here is just to see how much the doctors care for the patients and also how much theyre invested in training us as medical students.

We dont have a class above us being the first class, and Ive been able to find mentors and physicians who are so committed to our medical school journey. These are relationships that I very much treasure.

While she considers Washington home now, Tham has lived in three countries.

Her journey to WSU began with a childhood in Singapore, where she was born, until moving to Canada with her family at age 10. Tham later made Washington her permanent home moving to Seattle just before entering the University of Washington on a gymnastics scholarship.

Her mother studied in the U.S. for college, she said, and wanted to move Tham and her younger brother here. Thams mom, brother and stepdad now also live in the state.

Tham completed a biology major, then worked two years for a Seattle-area pain management practice, where she decided to pursue medicine. The clinic introduced her to working in clinical research and helping to take care of patients.

When applying to schools, it was the year that WSU had opened its medical college applications, and Tham wanted to stay in-state.

During their first two years here in Spokane, many of the medical students bonded over playing basketball, she said. Tham also joined classmates in forming Spokane Hoopfest teams.

Another favorite part of being here, Tham said, was enjoying the Spokane food scene and trying different restaurants as they opened.

For the third- and fourth-year training, she and classmates had opportunities at all regional hospitals, Sacred Heart, Deaconess and the VA doing some of our core rotations and then our specialty rotations all with the community physicians, for me, here in Spokane.

When she completes her anesthesiology residency training, Tham said that where in the state she ends up will depend on work opportunities. Some of her classmates have mentioned their plans to return to rural hometowns.

I know of some classmates who were born and raised in a more rural community in Washington and have full intentions of returning back there to provide health care for their communities, she said.

She and classmates also enjoyed watching as other classes of medical students arrived at WSU, she said. Theyve been able to do some mentoring for them as members of the first class.

I feel so fortunate and blessed to be in the position I am, that WSU opened the school to train new medical students and how grateful I am for the community physicians who have been willing to teach us and mentor us through becoming doctors.

The rest is here:
The first class: WSU's new medical school is graduating its first 60 students in the spring - The Spokesman-Review

UC Davis is currently vaccinating patients 65 and older. To find out when they are eligible, patients can register for an account with MyUCDavisHealth

Having only worked at UC Davis for six months before the outbreak of COVID-19, Dr. Allison Brashear, the dean of the UC Davis School of Medicine, said that partnering with the UC Davis campus has been crucial when adjusting to the ever-changing conditions of the pandemic. On March 2, 2020, Brashear met with over 25 researchers and clinicians to discuss pandemic operations.

We had a call to action on March 2, with the campus and the School of Medicine on what are we going to do about the pandemic, clinical trials, developing, testing [and] improving patient care, Brashear said. And everybody jumped in with both feet in terms of getting research approved and moving forward developing testing and really working as one team.

Before coming to UC Davis, Brashear worked as the chair of the Department of Neurology at Wake Forest University for 15 years. Now, as the dean for UC Davis Health, she said that her role has evolved during the pandemic to focus on strategy and operations. She has also participated in new initiatives such as a Deans Call and a Deans Discuss Podcast in collaboration with the School of Veterinary Medicine.

Beginning on March 2, we developed a daily Deans Call which we did for almost two months, Brashear said. We still have those Deans Calls twice a week, where we actually real-time problem-solve issues about surge testing [or] vaccinations.

Less than two weeks after the meeting in early March, UC Davis Health developed its own internal rapid testing system where tests were run through an onsite machine instead of outsourced to a lab. The university also pioneered the saliva test on Nov. 10, 2020, and initiated clinical trials relating to the vaccine, the most recent in late Dec. 2020.

According to Brashear, she is most proud of UC Davis adaptability and swift development of testing and clinical trials.

Im particularly proud of the inclusion of research in our day-to-day clinical care, Brashear said. That goes from standing up a test in the middle of March to bringing clinical trials in record time to our patients at the bedside and in the clinics.

Since the development of different varieties of COVID-19 vaccines, UC Davis has administered over 17,000 vaccines in total and is currently vaccinating patients 65 and older.

As the vaccination rollout continues, Brashear said that she hopes for other vaccines to be approved in the near future to allow for more widespread vaccination.

There have been some challenges about the vaccine rollout, Brashear said. We are looking forward to additional vaccines being approved, including AstraZeneca and Johnson & Johnson. In general, one of the challenges has been lots of people that want the vaccine but not enough providers to deliver the vaccine.

According to her, UC Davis has thus far been a model in safety and in vaccination of its frontline healthcare workers.

Our goal is to really vaccinate our health care workers so that we can make sure that they are all safe, Brashear said. Our frontline workers are a priority. About 82% of our [health care workers] have been vaccinated with at least one shot.

Brashear stated that she is grateful overall for the work UC Davis Health has been able to accomplish, bolstered by a partnership with the campus.

Im really proud of the collaboration with main campus to really improve [the] health of our patients at UC Davis Health but also to move science forward, Brashear said. Its really been a team effort over the last 10 months.

To find more information about receiving the COVID-19 vaccine, patients can create an account with MyUCDavisHealth. Patients will be notified when they are eligible to be vaccinated.

Written by: Sophie Dewees features@theaggie.org

Excerpt from:
The dean of the UC Davis Medical School discusses the vaccination rollout, patient care - The Aggie

The Department of Internal Medicine is pleased to announce the following appointments and promotions to Professor of Medicine. Michael P. DiGiovanna, MD, PhD, and Emily Wang, MD, were promoted to Professor of Medicine. Robert Bona, MD, was newly recruited to Yale and appointed Professor of Medicine.

Co-Director, Pre-Clerkship CurriculumPharmacology Thread LeaderCo-Leader, Genes & Development Master CourseMD: Yale School of MedicinePhD: Yale School of Medicine Residency: Yale New Haven HospitalPostdoctoral Fellow: Yale School of MedicineFellowship: Yale New Haven Hospital

Michael P. DiGiovanna, MD, PhD, attended Yale School of Medicine earning an MD and a PhD in pharmacology. He completed his post-graduate training at Yale, with an internship and residency in internal medicine, a research post-doctoral fellowship, and a clinical fellowship in medical oncology. His clinical specialty is breast cancer oncology; he conducts both clinical and laboratory-based research into the treatment and of breast cancer. He has had a leadership role in medical education in the school, overseeing a large component of the medical student curriculum.

What does your promotion mean to you? The promotion is a much-appreciated acknowledgment from peers that the work one does is valued.

What was the first thing you did when you found out you were promoted to professor? I shared the good news with family.

What are you proud of most thus far in your career? Being able to contribute substantially in all three areas of the academic medical center mission: patient care, research, and education.

What is your favorite part of academia? Translating new research results into practice.

Tell us a fun fact about yousomething people may find surprising. I'm a highly trained musician. In college I double-majored in biochemistry and music. Also, I play mens league ice hockey two nights per week (when a pandemic doesnt result in rink closure).

Director, SEICHE Center for Health and JusticeHealth Justice Lab research program leadCo-founder, Transitions Clinic NetworkMD: Duke University Medical Center Intern: University of California, San FranciscoResidency: University of California, San FranciscoMAS: University of California, San Francisco

Emily Wang, MD, directs the SEICHE Center for Health and Justice, a collaboration between Yale School of Medicine and Yale Law School. The Center works to stimulate community transformation by identifying the legal, policy, and practice levers that can improve the health of individuals and communities impacted by mass incarceration. She also leads the Health Justice Lab research program that investigates how incarceration influences chronic health conditions, including cardiovascular disease, cancer, and opioid use disorder. As an internist, she cares for many individuals with a history of incarceration and is co-founder of the Transitions Clinic Network, a consortium of 40 community health centers nationwide employing community health workers with histories of incarceration. Wang recently co-chaired the National Academy of Sciences consensus report on decarcerating correctional facilities during COVID-19.

What does your promotion mean to you? I am hoping that students, residents, people starting out at Yale will see my promotion as a sign that a career grounded in social justice in an academic medical center is possible, rewarding, and joyful.

What was the first thing you did when you found out you were promoted to professor? I told my family.

What are you proud of most thus far in your career? am most proud when my team and community thrive: when patients who have been out of prison for a decade are meaningfully employed and reunited with family, when medical students go on to become physician leaders caring for justice-involved patients, when fellows land jobs in academia and the public sector contributing to the science and practice of decarceration, and when my team members succeed in changing the practices, policies, and culture of our institutions to support people impacted by mass incarceration.

What is your favorite part of academia? That I am able to work on something that I care so deeply about.

Fun fact about yousomething people may find surprising. Favorite song to karaoke: Livin on a Prayer

Director, Benign Hematology ProgramMedical Director, Hemophilia Treatment CenterMD: SUNY Upstate Medical Center Residency: Rhode Island Hospital, Brown UniversityFellowship: UConn School of Medicine

Originally from New York, Robert Bona, MD, and his wife, Georg'Ann, currently live in New Haven and are long-time residents of Connecticut where they raised their three children. Before to coming to Yale, Dr. Bona was a founding faculty member of the Frank H. Netter School of Medicine at Quinnipiac University. He previously was Professor of Medicine at the University of Connecticut School of Medicine, where he served as the hematology oncology fellowship program director, chief of the division of hematology oncology, and hemophilia treatment center director. He has had a strong interest throughout his career, in medical education and clinical hemostasis and thrombosis.

What does your appointment mean to you? I'm humbled and honored to be appointed at this level at the Yale School of Medicine.

What was the first thing you did when you found out about your appointment? I told my wife who offered congratulations: That is really an accomplishment you should be proud of!

What are you proud of most thus far in your career? I think I have made a difference in the lives of patients and their families either through medical knowledge and application or by being present for them during times of need.

What is your favorite part of academia? Being a piece of the educational mission of a medical school has been extremely gratifying. I enjoy teaching and learning from students, residents, fellows, nurses, social workers and others involved in the care of patients. Career advising and being able to share some of my experiences with trainees in order for them to make decisions about their careers is also very gratifying.

Fun fact about yousomething people may find surprising. I'm trying to learn to play guitar. I started taking lessons a few years ago, which have been interrupted due to the COVID pandemic. Also, I coached my kids baseball/softball teams for almost 20 years--great fun!

Read the original:
New Professors Within the Department of Internal Medicine - Yale School of Medicine

BALTIMORE, Feb. 12, 2021 /PRNewswire/ -- University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been appointed to serve as the Chair of the Department of Psychiatry, effective immediately. Dr. RachBeisel has served as the Department's Interim Chair for the past two years and was previously Acting Chair and Vice Chair of the Department. A prominent leader at UMSOM, she has garnered tremendous support among faculty and staff for her efforts to forge partnerships among various entities in an effort to strengthen mental health services provided to patients and the community at large. Dr. RachBeisel will be named The Dr. Irving J. Taylor Endowed Professor and Chair, Department of Psychiatry, when she is invested March 18.

The appointment of Dr. RachBeisel was recommended by a Dean-appointed Review Committee led by Peter B. Crino, MD, PhD, Professor and Chair, Department of Neurology, and Rodney J. Taylor, MD, MPH, Professor and Chair, Department of Otorhinolaryngology-Head & Neck Surgery. After extensive review, the committee unanimously recommended to Dean Reece that she be considered for the permanent chair position.

For more than 20 years, Dr. RachBeisel has played an increasing role in leading the Department's clinical and academic activities, and in leading the integration of the UMSOM's Department's academic programs with the University of Maryland Medical System (UMMS), University of Maryland Medical Center (UMMC), as well as with the State of Maryland and City of Baltimore.

"Dr. RachBeisel is a tremendous leader and has had an enormous impact on the department during her terms as Interim Chair, Acting Chair, and Vice Chair. She has built lasting bridges between UMSOM and UMMS/UMMC, as well as bridges between UMSOM and the community at large which have benefitted greatly from her efforts to expand mental health services to those in need, " said Dean Reece, who is also Executive Vice President for Medical Affairs and the John Z. and Akiko K. Bowers Distinguished Professor. "She is highly respected across our academic community and has demonstrated unwavering and effective leadership throughout the years. Her gift for building partnerships between researchers and clinicians to create innovative and highly successful initiatives is remarkable and highly desirable."

Under her leadership as Interim Chair, Dr. RachBeisel has focused on building vital and lasting collaborations to strengthen the Department's infrastructure to support faculty growth and development, and the fusion of research and clinical agendas.

"Dr. RachBeisel is a phenomenally talented clinician, educator and mentor to our medical trainees and behavioral health specialists," said Bert W. O'Malley, Jr., MD, President and Chief Executive Officer of the University of Maryland Medical Center (UMMC). "She has been a guiding light and inspiration to our hospital staff during this stressful time of the global pandemic. Her passion for designing programs that span a spectrum of settings and for partnering with colleagues to provide integrated behavioral care expertise is invaluable."

The Department of Psychiatry received research and service grants totaling $43 million for fiscal year 2020 from the National Institutes of Health and elsewhere. Dr. RachBeisel worked with Dean Reece to establish the Vice Chair of Research and appointed Gloria Reeves, MD, Associate Professor of Psychiatry, to serve in this role. Other successful efforts include the establishment of the "Foundation Academy" to assist faculty in learning the intricacies of working effectively and successfully with non-profit foundations and to help prepare successful grant submissions. A newly established and formalized Mentoring Program for all new and mid-level faculty was also implemented to enhance faculty growth, professional development, and promotion leading to enhanced clinical and research success.

Dr. RachBeisel is the first woman to chair the UMSOM Department of Psychiatry. Immediately after assuming the interim chair position, Dr. RachBeisel established the Department of Psychiatry's Diversity, Equity, and Inclusion (DEI) Committee, chaired by Anique Forrester, MD, Assistant Professor of Psychiatry. The committee has focused on developing a training curriculum and diversifying the hiring of faculty and staff. They also have collaborated on efforts to retain new hires and maintain momentum to facilitate change. With support from a highly engaged faculty and resident group, Dr. RachBeisel also created a DEI lecture series that began last fall and will run through FY21.

"I am proud and honored to be taking the permanent helm of this department with its devoted faculty and staff," said Dr. RachBeisel. "Together we have risen to the challenges of the past year and have worked as a united team to sustain our programs and meet the increased needs of our patients and the campus workforce during the pandemic and the movement against racial injustice."

Heralded for her clinical achievements, Dr. RachBeisel helped spearhead the 2019 opening of two new state-of-the-art units-an adult inpatient behavioral health unit and the adult day hospital program at the University of Maryland Medical Center Midtown Campus (MTC). The programs, designed to optimize patient experience and safety, are led byStephanie Knight, MD, Assistant Professor of Psychiatry and Chief of Psychiatry at MTC. They are staffed by nurses, social workers, occupational and recreational therapists, addiction, counselors, and clinical nurse educators.

Dr. RachBeisel has also played a key role in developing a new partnership with other Baltimore area hospitals to strengthen and expand the crisis response infrastructure and community-based services to Baltimore City and its three surrounding counties. The Greater Baltimore Regional Integrated Crisis System (GBRICS) Partnership will enable UMMC to expand its Assertive Community Treatment (ACT) programs for adults and children, statewide tele-mental health program, and extensive addictions care program.

"Dr. RachBeisel has been instrumental in helping us develop and implement robust and evidence-based programs to provide expert, compassionate, team-based care for our community, including the citizens of West Baltimore, the City of Baltimore, and the region," said Alison Brown, MPH, President, University of Maryland Medical Center Midtown Campus. "We are so excited to have her continue permanently in this leadership role."

Serving as a faculty member in the Department of Psychiatry since 1989, Dr. RachBeisel began her career in the field of acute psychiatric care, emergency psychiatric interventions, and quality management in the hospital setting. She received her BS Degree in Chemistry and Mathematics from Carlow College in Pittsburgh, PA, and her RN Certification from the Western Pennsylvania School of Nursing. She then went on to complete her medical degree in 1985 from Pennsylvania State University School of Medicine. She completed her Psychiatric Residency Program at the University of Maryland Medical Center in 1989, serving as chief resident during her fourth year.

During her tenure at the UMSOM, Dr. RachBeisel has held numerous leadership positions at the Institute of Psychiatry and Human Behavior and served as the Division Director for Community Psychiatry at the University of Maryland Medical Center, overseeing 200 staff and physicians and providing a range of community mental health services. Through collaborations with the Division of Psychiatric Services Research, she became focused on the study of implementation of evidenced-based care for persons with a serious mental illness. In addition to her Division responsibilities, Dr. RachBeisel has been Chief of Clinical Services for the Department of Psychiatry since 2014, providing oversight of program development, performance improvement, and collaboration with the research divisions within the Department.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 45 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.2 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for nearly 2 million patients each year. The School of Medicine has more than $563 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 students, trainees, residents, and fellows. The combined School of Medicine and Medical System ("University of Maryland Medicine") has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu

About the University of Maryland Medical Center

The University of Maryland Medical Center (UMMC) is comprised of two hospital campuses in Baltimore: the 800-bed flagship institution of the 14-hospital University of Maryland Medical System (UMMS) -- and the 200-bed UMMC Midtown Campus, both academic medical centers training physicians and health professionals and pursuing research and innovation to improve health. UMMC's downtown campus is a national and regional referral center for trauma, cancer care, neurosciences, advanced cardiovascular care, women's and children's health, and has one of the largest solid organ transplant programs in the country. All physicians on staff at the downtown campus are clinical faculty physicians of the University of Maryland School of Medicine. The UMMC Midtown Campus medical staff is predominately faculty physicians specializing in diabetes, chronic diseases, behavioral health, long term acute care and an array of outpatient primary care and specialty services. UMMC Midtown has been a teaching hospital for 140 years and is located one mile away from the downtown campus. For more information, visit http://www.umm.edu.

This news release was issued on behalf of Newswise For more information, visit http://www.newswise.com

View original content:http://www.prnewswire.com/news-releases/dr-jill-rachbeisel-appointed-chair-of-the-department-of-psychiatry-at-the-um-school-of-medicine-301227492.html

SOURCE University of Maryland School of Medicine

See the original post here:
Dr. Jill Rachbeisel, Appointed Chair Of The Department Of Psychiatry At The UM School Of Medicine - Herald-Mail Media

This year there were nearly 3,500 applicants wanting to attend the school.

DULUTH, Minn. More people are filling out applications to attend the University of Minnesota Medical School campuses including in Duluth.

There are many factors that may play into the increase of applicants, but U of M Medical School officials say it is impressive knowing so many people are willing to dedicate to a career in healthcare.

In a typical year, the University of Minnesota Medical School Duluth Campus receives about 2000 applications.

This year there were nearly 3,500 applicants wanting to attend the school.

This is approximately an increase of more than 75% for the Duluth campus, which houses about 300 medical students.

Admission officials believe the pandemic is highlighting the value of healthcare for these applicants.

Theyre seeing the pandemic really impacting their lives, their families, their friends, and their communities. Its driving them to pursue a career in medicine that they may have been on the track for, but are really passionate about now because now is the time, said Dr. Kendra Nordgren, the assistant dean of admission at the U of M Medical School Duluth Campus.

In recent years, there has been a strong need for family physicians in rural and under-represented populations like the native community.

Leadership says the medical school has been on a mission to fill the gap for the last 50 years.

Now more than ever its so important that we see this uptick because it shows us that there are candidates out there and there are people that want to serve these communities, said Nordgren.

In 2019, the U of M Medical School Duluth Campus welcomed a record number of incoming Native American students on track to becoming physicians.

The Twin Cities campus has also seen about a 45% jump in the number of applications to the medical school.

Originally posted here:
U Of M Medical School Sees Increase In Student Applications - FOX 21 Online

Gabrielle Klaessig of Peterborough, a homeschooled high school junior who is attending early college classes at NHTI of Concord, is a Delegate to the Congress of Future Medical Leaders on March 20 and 21.

The Congress is an honors-only program for high school students who want to become physicians or go into medical research fields. The event is intended to honor, inspire, motivate and direct the top students in the country interested in medical careers and to provide resources to help them reach their goals.

Klaessigs nomination was signed by Dr. Mario Capecchi, winner of the Nobel Prize in Medicine and the Science Director of the National Academy of Future Physicians and Medical Scientists. Klaessig was nominated to represent New Hampshire based on her academic achievement, leadership potential and determination to serve humanity in the field of medicine.

During the two-day Congress, Klaessig will join students from across the country and hear Nobel Laureates and National Medal of Science winners talk about leading medical research; be given advice from top medical school deans on what to expect; witness stories told by patients whove benefitted from advanced medicine; be inspired by fellow teen medical science prodigies; and learn about cutting-edge advances and the future in medicine and medical technology.

Based in Washington, D.C. and with offices in Boston, The National Academy of Future Physicians and Medical Scientists was chartered as a nonpartisan, taxpaying institution to help address this need for physicians by working to identify, encourage and mentor students who wish to devote their lives to the service of humanity.

For more information visit http://www.FutureDocs.com or call 617-307-7425.

Read more from the original source:
Peterborough student nominated for The Congress of Future Medical Leaders - The Keene Sentinel

Photo by Mitchell Atencio | The State Press

"University officials credit the success to their transdisciplinary approach to major problems, claiming a different path of solutions than traditional research." Illustration published on Tuesday, Feb. 9, 2021.

ASU has ranked 6th in the nation for research expenditures among universities without a medical school in the 2019 fiscal year.

The National Science Foundation recently released its annual Higher Education Research and Development rankings for research expenditures among universities nationwide.

In the 2019 fiscal year, ASU's expenditures totaled $639.6 million, almost $22 million more than the previous year.

A University press release said much of the funding has come from investments by federal agencies including NASA and the NSF as well as local grants and philanthropic contributions among others.

ASUs Knowledge Enterprise Executive Vice President Sally Morton said in the press release that ASU researchers are capable of solving major problems through their transdisciplinary approach. Morton began her new role Feb. 1 and is one of the successors of former lead Sethuraman Panchanathan, who is now the director of the NSF.

"I am confident we have the capabilities to discover impactful solutions to pandemics, climate change, cybersecurity and emerging health issues all of which will challenge humankind well into the future," Morton said in the release.

ASU's Biodesign Institute has also been at the forefront of COVID-19 research and testing in Arizona. The University has established over 100 testing sites across the state and developed a saliva-based test for faster results and more efficient testing.

COVID-19 research at the institute is led by Biodesign Director Joshua LaBaer. LaBaer said in the release that fast and easy testing is crucial for returning to in-person activities.

As we return to the workplace, schools and other daily activities, testing early and often is going to be the best way to help us prevent the spread of COVID-19, LaBaer said in the press release.

Another of the University's recent focal points is the Mastcam-Z. The camera system will provide visuals for Perseverance, the newest Mars rover, upon its landing this month.

The development of Mastcam-Z was led by researchers of the School of Earth and Space Exploration. The rover launched in July 2020 and will touch down on Mars later this month with Mastcam-Z at its head.

READ MORE: Mars 2020 Perseverance rover launches equipped with ASU-developed camera

The HERD rankings account for where and how much funding is spent at each university. In these rankings, ASU kept its No. 1 spot in expenditures for anthropology and rose to No. 1 in the fields of geographic and earth sciences as well as transdisciplinary sciences.

ASU also ranked fourth in social sciences and business management, 11th in psychology, 12th in electrical, electronic and communications engineering, and 14th in civil engineering.

The University also placed third among universities with NASA funding, 10th in health and human services funding, and 23rd for NSF funding.

Reach the reporter at gmlieber@asu.edu and follow @G_Mira_ on Twitter.

Like The State Press on Facebook and follow @statepress on Twitter.

Continue supporting student journalism and donate to The State Press today.

Link:
ASU ranks 6th in research among US universities without a medical school - The State Press

As Minnesota students continue to go back to the classroom some after nearly a whole year of distance learning via Zoom an impassioned debate over how to safely open schools amid an ongoing pandemic has only intensified, mired in the politics of the statehouse, school districts and teachers unions.

Those who want kids back in school point out that remote learning is exacerbating achievement gaps already very present in Minnesotas education system. Others worry kids are suffering social, mental and learning setbacks as a result of staying home.

Advocates of continuing distance learning cite ongoing transmission of the COVID-19 virus, a shortage of vaccines that makes them unavailable to many teachers, and the need to keep both kids and their families at home safe.

What does the science say about whether its safe to resume in-person schooling?

These questions are coming to a head at the national level as the Biden administration prepares to release federal-level guidance on reopening schools as early as this week. In January, President Joe Biden set a goal to open most schools within his first 100 days in office (around mid-April). More recently, the administration lowered expectations, saying the goal would be to have more than half of schools have some in-person teaching at least one day a week by the hundredth day. Hes also proposed more than $130 billion funding to pay for increased school staffing, ventilation improvements and protective equipment.

Until recently, much of the research on the reopening of schools amid COVID-19 had come from overseas, conducted in countries that had a better handle on the pandemic than the U.S. (The U.S. accounts for less than 5 percent of the worlds population and 20 percent of its documented COVID-19 deaths to-date.)

Article continues after advertisement

But theres a growing acknowledgment that schools may be able to reopen relatively safely in the U.S., even in spite of still-uncontrolled levels of COVID-19. Last month, the Centers for Disease Control and Prevention (CDC) released research published in the Journal of the American Medical Association that suggests schools may pose little risk of COVID-19 transmission compared to their surrounding communities when following proper COVID-19 mitigation measures, such as the use of masks, distancing and keeping students in smaller groups.

The CDC tracked COVID-19 in 17 K-12 schools with 4,876 in-person students in rural Wood County, Wisconsin, between Aug. 31 and Nov. 29, 2020, a time that included massive escalation in Wisconsins statewide COVID-19 case rates. The schools used several mitigation strategies to reduce the likelihood of COVID-19 transmission: classes were limited to between 11 and 20 kids who stuck together throughout the school day; everyone maintained 6 feet of distance whenever possible and used masks (a grant helped buy students layered masks); and the school quarantined people who had been exposed to the virus.

During the study, 191 cases of COVID-19 were identified among the 4,876 students and 654 staff, seven of which (all students) were believed to have been tied to schools.

While students were not systematically tested for COVID-19, the rate of cases in schools was much lower than it was in the community at the time: 3,463 cases per 100,000 residents for people who were attending schools (which included cases among school-goers who got the disease in the community) versus 5,466 cases per 100,000 residents in the county at-large. That led the researchers to conclude that even in communities with high levels of COVID-19 transmission, students and staff may be more likely to pick up the virus in the community than in schools when proper mitigation strategies are used.

Article continues after advertisement

Wisconsin was right in the middle of a community outbreak at that point in time, but they actually saw very little transmission in the school, said Dr. Beth Thielen, an infectious disease physician with the University of Minnesota Medical School and M Health Fairview.

Instead, the research found students and staff members much more often getting COVID-19 in the community and rarely spreading it in schools. That, to me, was very interesting because it showed even in a setting of community transmission you can actually contain the virus, Thielen said.

Thielen sees the mismatch between infection rates in the community and within schools as a suggestion that doubling down on infection control measures could help. People, she said, arent very good at assessing what activities are risky.

Dr. Beth Thielen

Of course, adherence to transmission-reducing mitigation strategies appears to be a significant factor in the level of spread in schools, Thielen said.

As of Thursday, Minnesota had listed 71 schools with COVID-19 outbreaks, meaning they had five or more cases among students or staff who spent time in the school building while they were infectious during a two-week period. That doesnt mean those cases were necessarily picked up in school.

The Wisconsin data, which differs from early studies done across the world in that it seems pretty much as close as you can get to Minnesota, Thielen said, suggests it might be possible to do in-person school safely.

The Wisconsin study cited several limitations to its data, among them that mask-wearing data was obtained through an unscientific survey; the study didnt explore a causal relationship between the mitigation strategies and low disease spread; it did not collect data on ventilation; did not track asymptomatic spread through screening (though research through blood tests has found spread among young children, symptomatic or not, to be minimal).

The Wisconsin study isnt the only one in the U.S. to find that cases in schools, with proper measures in place, can be lower than in the community. A study by Duke University and the University of North Carolina Chapel Hill, released in January, found that in a given period among 100,000 K-12 students and staff in 11 districts in North Carolina, there were 773 community-acquired infections and 32 school-acquired ones.

Other studies have suggested certain conditions should be met before schools reopen.

Article continues after advertisement

A Tulane University study based on national data that was published in December found that when new COVID-19 hospitalizations were at lower levels, between 36 per 100,000 residents and 44 per 100,000 residents per week, the opening of schools did not have a discernible effect on COVID-19 hospitalizations. When hospitalizations were at higher levels, though, the effect of opening schools was less clear. The researchers have been keeping data updated and as of the last week of data, the most recent update, all of Minnesotas counties but one, Olmsted, were below the hospitalization range cited as low level in the study.

A study on Michigan and Washington schools, likewise, found that where transmission was low, the opening of schools didnt seem to have an effect.

Another study, from Florida, found that COVID-19 infections increased among high school students after schools reopened (there is evidence that younger children are less likely to transmit the virus as compared to older ones).

But while the U.S.-based research is starting to coalesce around conditions under which it might be safe to reopen schools, theres one big caveat: We dont yet know what new variants of COVID-19 that have emerged and are expected to begin circulating more widely in the U.S. mean for all this schools research, which is predicated on plain old COVID-19.

Still, as research piles up, officials at the top levels of government are articulating that it might be time to open schools, under the right conditions. On Thursday, CBS News reported that a draft summary of forthcoming CDC recommendations includes phased reopening based on community transmission levels. And Dr. Anthony Fauci has supported getting students back in the classroom based on CDC findings.

I would back the CDC recommendations because that is really based on data, Fauci said in an interview in January after the release of the findings. We didnt fully appreciate that early on but the fact is that when you look at a community and look at the penetrance of the virus in the community and its spread at the community level compared to the school in that community, its less likely for a child to get infected in a school setting than if they were in the community.

The rest is here:
More Minnesota students are heading back to school. What does the science say about the safety of reopening? - MinnPost